Innovative Drug Delivery Implant for Chronic Disease Management

Overview of Chronic Disease Challenges

A recent study highlights the potential of a remote-controlled drug delivery implant in managing chronic diseases. Millions globally are affected by conditions such as rheumatoid arthritis and diabetes, necessitating ongoing treatment solutions.

Research Insights on Drug Delivery Device

The research focused on the advantages of an implantable drug delivery device designed to enhance chronic disease management. This study utilized an in-vitro device capable of releasing medication remotely, serving as an initial treatment option for high blood pressure and rheumatoid arthritis.

Details of the Nanochannel Delivery System

Conducted by researchers at the Houston Methodist Research Institute, the study employed a Bluetooth-controlled device to provide continuous dosages of two medications for chronic diseases. Known as the nanochannel delivery system (nDS), this device operates without pumps, valves, or an external power supply, allowing it to function for up to a year without requiring refills.

Device Functionality and Advantages

The nDS is battery-operated and features a microchip that facilitates wireless communication. Implanted beneath the skin, it is programmed to deliver medication on three adjustable settings: standard, decreased, and increased. This innovative device represents a significant advancement over existing medical devices, such as insulin pumps and pain management implants, which require external ports or regular refills.

Personalization and Longevity of Treatment

One of the notable benefits of the nDS is its ability to tailor medication dosage and scheduling to individual patient needs, providing treatment for months or even years before needing a refill.

Future Research Directions

While additional studies and advancements are necessary, this research lays the groundwork for future explorations into chronic disease management and the application of similar medical devices.

References

Trani, N.D., Silvestri, A., Bruno, G., Geninatti, T., …, Grattoni, A. (2019). Remotely controlled nanofluidic implantable platform for tunable drug delivery. Lab on a Chip. doi: 10.1039/c9lc00394k
Smith, G. (2019). Remote-controlled drug delivery implant size of grape may help chronic disease management. Retrieved from https://www.eurekalert.org/pub_releases/2019-06/hm-rdd062119.php

Photo credit: Houston Methodist